Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9364567 Fragments of p97 and uses thereof

Patent 9364567 was granted and assigned to biOasis Technologies on June, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

biOasis Technologies

0

Current Assignee

biOasis Technologies

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Timothy Z. Vitalis0

Reinhard Gabathuler0

Date of Patent

June 14, 2016

0

Patent Application Number

142100290

Date Filed

March 13, 2014

0

Patent Citations Received

US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes

0

US Patent 12129294 Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

0

US Patent 12122826 Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

0

US Patent 11884944 Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof

0

Patent Primary Examiner

0

Patent abstract

Provided are fragments of human p97 (melanotransferrin) polypeptides having blood-brain barrier (BBB) transport activity, including variants and combinations thereof, conjugates comprising the p97 fragments, and related methods of use thereof, for instance, to facilitate delivery of therapeutic or diagnostic agents across the BBB.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9364567 Fragments of p97 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool